Article
KRAS, NRAS, BRAF, and PIK3CA mutation rates, clinicopathological association, and their prognostic value in Iranian colorectal cancer patients.
Journal of clinical laboratory analysis - 1 Mar 2023
Mirzapoor Abbasabadi Zohreh, Hamedi Asl Dariush, Rahmani Babak, Shahbadori Rozhin, Karami Sara, Peymani Amir, Taghizadeh Sara, Samiee Rad Fatemeh
Abstract excerpt
AIM: Mutations in KRAS, NRAS, BRAF, and PIK3CA genes are critical factors in clinical evaluation of colorectal cancer (CRC) development and progression. In Iran, however, the data regarding genetic profile of CRC patients is limited except for KRAS exon2 and BRAF V600F mutations. This study aimed to investigate the mutational spectrum and prognostic effects of these genes and explore the relationship between...
Topics
- Colorectal Neoplasms
- Mutation
- Prognosis
- Iran
- Proto-Oncogene Proteins p21(ras)
- Membrane Proteins
- GTP Phosphohydrolases
- Proto-Oncogene Proteins B-raf
- Class I Phosphatidylinositol 3-Kinases
